Comparison between Kamdhenu Ispat IPO and Plethico Pharmaceuticals IPO.
Kamdhenu Ispat IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Kamdhenu Ispat IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Logo | ||
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ||
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus  | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Kamdhenu Ispat IPO is up to ₹22.81 Cr whereas the issue size of the Plethico Pharmaceuticals IPO is up to ₹110.00 Cr. The final issue price of Kamdhenu Ispat IPO is ₹25.00 per share and of Plethico Pharmaceuticals IPO is ₹300.00 per share.
| Kamdhenu Ispat IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹280.00 per share | |
| Issue Price (Upper) | ₹300.00 per share | |
| Issue Price (Final) | ₹25.00 per share | ₹300.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 91,25,300 shares | 36,66,667 shares |
| Fresh Issue Size (Amount) | up to ₹22.81 Cr | up to ₹110.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 91,25,300 shares | 36,66,667 shares |
| Issue Size Total (Amount) | up to ₹22.81 Cr | up to ₹110.00 Cr |
Kamdhenu Ispat IPO opens on Apr 03, 2006, while Plethico Pharmaceuticals IPO opens on Apr 10, 2006. The closing date of Kamdhenu Ispat IPO and Plethico Pharmaceuticals IPO is Apr 08, 2006, and Apr 17, 2006, respectively.
Kamdhenu Ispat IPO P/E ratio is , as compared to Plethico Pharmaceuticals IPO P/E ratio of .
| Kamdhenu Ispat IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 94.38 | 97.5 |
| Promoter Shareholding (Post-Issue) | 50.12 | 87.01 |
| P/E Ratio | ||
| Market Cap | ₹47.53 Cr. | ₹1022.00 Cr. |
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Kamdhenu Ispat IPO Retail Individual Investors (RII) are offered 45,62,650 shares while in Plethico Pharmaceuticals IPO retail investors are offered 45,62,650 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Kamdhenu Ispat IPO and 22,00,000 shares in Plethico Pharmaceuticals IPO.
| Kamdhenu Ispat IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 22,00,000 shares |
| NII | 45,62,650 shares | 3,66,667 shares |
| RII | 45,62,650 shares | 11,00,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 91,25,300 shares | 36,66,667 shares |
Kamdhenu Ispat IPO subscribed in total, whereas Plethico Pharmaceuticals IPO subscribed .
